C. Greene (Dublin, Ireland), J.H.J. Vernooy (Maastricht, Netherlands)
Cigarette smoke upregulates IL-8/CXCL8 expression by augmenting mRNA stability via p38 MAPK/MK2 signalling in normal human pulmonary cells
N. Moretto, G. Volpi, M. Kaur, C. Iadicicco, S. Bertolini, G. Marchini, D. Singh, F. Facchinetti (Parma, Italy; Manchester, United Kingdom)
|   |
Pharmacological inhibition of epidermal growth factor receptor modulates cigarette smoke-induced CXCL8 release but not VEGF release
G. Volpi, N. Moretto, R. Patacchini, F. Facchinetti (Parma, Italy)
| |
Cigarette smoke suppresses mast cell maturation and cytokine release independent of TLR4 signaling
E. Mortaz, C. Silva, G. Folkerts, J. Garssen, R. Redegeld (Utrecht, Netherlands; Tehran, Islamic Republic Of Iran; Mölndal, Sweden)
| |
Regulation of immunoproteasomes by cigarette smoke
I. Keller, A.O. Yildirim, O. Eickelberg, S. Meiners (Munich, Neuherberg, Germany)
| |
Effect of cigarette smoke on peripheral blood Th17 (PBTh17) cells from COPD patients. Role of acetylcholine
M. Profita, G.D. Allbano, C. Di Sano, A.M. Montalbano, R. Gagliardo, G. Anzalone, L. Riccobono, A. Bonanno, M.P. Pieper, M. Gjomarkaj (Palermo, Italy; Biberach, Germany)
| |
Role of interferon-γ in tumor necrosis factor-α-mediated increase of lung microvascular endothelial cells
Y. Nakajima, Y. Nakamura, N. Suzuki, Y. Utsumi, N. Sasaki, K. Yamauchi (Morioka, Japan)
| |
Second hand smoke exposure impairs CD39 expression and function in the lung
A. Kratzer, J. Salys, J. Sévigny, M. Zamora, L. Taraseviciene-Stewart (Aurora, United States Of America; Quebec, Canada)
| |
TLR4 up-regulation and reduced Foxp3 expression in mechanically ventilated smokers with obstructive chronic bronchitis
E. Pace, M. Ferraro, A. Giarratano, C. Cipollina, M. Gjomarkaj (Palermo, Italy)
| |
Lectins improve efferocytosis via changes to cytoskeletal remodeling: Relevance to COPD
V. Mukaro, J. Byland, J. Ahern, M. Holmes, G. Hodge, P. Reynolds, S. Hodge (Adelaide, Australia; Gothenburg, Sweden)
| |
Enhanced cytotoxic function of NK and NKT-like cells associated with decreased CD94 (Kp43) in the airway in COPD
G. Hodge, V. Mukaro, M. Holmes, P. Reynolds, S. Hodge (Adelaide, Australia)
| |
The role of lL -17 and lymphoid follicles in the pathogenesis of COPD
K. Yadava, A. Trompette, A. Sichelstiel, L. Nicod, B. Marsland (Lausanne, Switzerland)
| |
Expansion of alveolar-lymphoid interfaces in lungs of patients with COPD
M. Mori, C. Andersson, K.A. Svedberg, A. Bergqvist, M. Shikhagaie, C.G. Löfdahl, J.S. Erjefält (Lund, Sweden)
| |
Diverse and altered distribution patterns of TLR5 and TLR7 in the distal lung of COPD patients
M. Shikhagaie, M. Mori, C. Andersson, A. Bergqvist, C.G. Löfdahl, J. Erjefält (Lund, Sweden)
| |
Metabolomic fingerprinting in the identification of biomarkers in COPD patients
F. Villar-Álvarez, A. García-Fernández, A. Ferrarini, J. Gómez-Seco, M. Rodríguez-Guzmán, J. Ruiz-Cabello, C. Barbas-Arribas, G. Peces-Barba (Madrid, Spain)
| |
Comparable matrix alterations in the alveolar and small airway wall of COPD patients
I.M.J. Eurlings, N.L. Reynaert, E.F.M. Wouters, M.A. Dentener (Maastricht, Netherlands)
| |
Corticosteroid insensitivity in airway smooth muscle cells of severe asthma and COPD: Modulation by IFN-γ
P.J. Chang, J. Baker, P.K. Bhavsar, M.M. Perry, K.F. Chung (London, United Kingdom; Taoyuan County, Taiwan)
| |
Inhaled corticosteroids (ICS) attenuates epithelial mesenchymal transition (EMT) in COPD: A key to understanding long term benefits?
S.S. Sohal, A. Soltani, D. Reid, C. Ward, S. Weston, H.K. Muller, R. Wood-Baker, E.H. Walters (Hobart, Brisbane, Australia; Newcastle-upon-Tyne, United Kingdom)
| |